A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors

Sponsor
Bristol-Myers Squibb

Protocol Number
CV202-103

To Learn More Call
201-510-0910